+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Bacterial And Plasmid Vectors Global Market Report 2022: By Host, By Application, By End-User

  • PDF Icon

    Report

  • 400 Pages
  • March 2022
  • Region: Global
  • The Business Research Company
  • ID: 5553725
Bacterial & Plasmid Vectors Global Market Report 2022 provides the strategists, marketers and senior management with the critical information they need to assess the global bacterial & plasmid vectors market.



This report focuses on the bacterial & plasmid vectors market which is experiencing strong growth. The report gives a guide to the bacterial & plasmid vectors market which will be shaping and changing our lives over the next ten years and beyond, including the market's response to the challenge of the global pandemic.

Reasons to Purchase


  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates
  • Create regional and country strategies on the basis of local data and analysis
  • Identify growth segments for investment
  • Outperform competitors using forecast data and the drivers and trends shaping the market
  • Understand customers based on the latest market research findings
  • Benchmark performance against key competitors
  • Utilize the relationships between key data sets for superior strategizing
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Description:


Where is the largest and fastest-growing market for bacterial & plasmid vectors? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Bacterial & Plasmid Vectors market global report answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider bacterial & plasmid vectors market and compares it with other markets.

  • The market characteristics section of the report defines and explains the market
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth
  • Market segmentations break down market into sub markets
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers
  • The bacterial & plasmid vectors market section of the report gives context. It compares the bacterial & plasmid vectors market with other segments of the bacterial & plasmid vectors market by size and growth, history and forecast. It analyses GDP proportion, expenditure per capita, bacterial & plasmid vectors indicators comparison

Scope


Markets Covered:


1) By Host Type: E.Coli Expression Vectors; Other Bacterial Expression Vectors
2) By Application: Genetics; Molecular Biology; Bioinformatics; Others
3) By End Users: Hospitals; Homecare; Specialty Clinics; Others

Companies Mentioned: Sigma-Aldrich Inc.; ATUM; QIAGEN; Promega Corporation; Thermo Fisher Scientific, Inc

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time-series: Five years historic and ten years forecast

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes
Frequently Asked Questions about the Global Bacterial & Plasmid Vectors Market

What is the estimated value of the Global Bacterial & Plasmid Vectors Market?

The Global Bacterial & Plasmid Vectors Market was estimated to be valued at $0.57 billion in 2022.

What is the growth rate of the Global Bacterial & Plasmid Vectors Market?

The growth rate of the Global Bacterial & Plasmid Vectors Market is 12.7%, with an estimated value of $0.92 billion by 2026.

What is the forecasted size of the Global Bacterial & Plasmid Vectors Market?

The Global Bacterial & Plasmid Vectors Market is estimated to be worth $0.92 billion by 2026.

Who are the key companies in the Global Bacterial & Plasmid Vectors Market?

Key companies in the Global Bacterial & Plasmid Vectors Market include Sigma, Aldrich inc., ATUM, QIAGEN, Promega Corporation, Thermo Fisher Scientific inc., GenScript Biotech Corporation, Takara Bio inc. and Bio.

Table of Contents

1. Executive Summary2. Bacterial & Plasmid Vectors Market Characteristics3. Bacterial & Plasmid Vectors Market Trends And Strategies4. Impact Of COVID-19 On Bacterial & Plasmid Vectors
5. Bacterial & Plasmid Vectors Market Size And Growth
5.1. Global Bacterial & Plasmid Vectors Historic Market, 2016-2021, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Bacterial & Plasmid Vectors Forecast Market, 2021-2026F, 2031F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Bacterial & Plasmid Vectors Market Segmentation
6.1. Global Bacterial & Plasmid Vectors Market, Segmentation By Host Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • E.Coli Expression Vectors
  • Other Bacterial Expression Vectors
6.2. Global Bacterial & Plasmid Vectors Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Genetics
  • Molecular biology
  • Bioinformatics
  • Others
6.3. Global Bacterial & Plasmid Vectors Market, Segmentation By End Users, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

7. Bacterial & Plasmid Vectors Market Regional And Country Analysis
7.1. Global Bacterial & Plasmid Vectors Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
7.2. Global Bacterial & Plasmid Vectors Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
8. Asia-Pacific Bacterial & Plasmid Vectors Market
8.1. Asia-Pacific Bacterial & Plasmid Vectors Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Bacterial & Plasmid Vectors Market, Segmentation By Host Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
8.3. Asia-Pacific Bacterial & Plasmid Vectors Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
9. China Bacterial & Plasmid Vectors Market
9.1. China Bacterial & Plasmid Vectors Market Overview
9.2. China Bacterial & Plasmid Vectors Market, Segmentation By Host Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion
9.3. China Bacterial & Plasmid Vectors Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion
10. India Bacterial & Plasmid Vectors Market
10.1. India Bacterial & Plasmid Vectors Market, Segmentation By Host Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
10.2. India Bacterial & Plasmid Vectors Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
11. Japan Bacterial & Plasmid Vectors Market
11.1. Japan Bacterial & Plasmid Vectors Market, Segmentation By Host Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
11.2. Japan Bacterial & Plasmid Vectors Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
12. Australia Bacterial & Plasmid Vectors Market
12.1. Australia Bacterial & Plasmid Vectors Market, Segmentation By Host Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
12.2. Australia Bacterial & Plasmid Vectors Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
13. Indonesia Bacterial & Plasmid Vectors Market
13.1. Indonesia Bacterial & Plasmid Vectors Market, Segmentation By Host Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
13.2. Indonesia Bacterial & Plasmid Vectors Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
14. South Korea Bacterial & Plasmid Vectors Market
14.1. South Korea Bacterial & Plasmid Vectors Market, Segmentation By Host Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
14.2. South Korea Bacterial & Plasmid Vectors Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
15. Western Europe Bacterial & Plasmid Vectors Market
15.1. Western Europe Bacterial & Plasmid Vectors Market Overview
15.2. Western Europe Bacterial & Plasmid Vectors Market, Segmentation By Host Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
15.3. Western Europe Bacterial & Plasmid Vectors Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
16. UK Bacterial & Plasmid Vectors Market
16.1. UK Bacterial & Plasmid Vectors Market, Segmentation By Host Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
16.2. UK Bacterial & Plasmid Vectors Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
17. Germany Bacterial & Plasmid Vectors Market
17.1. Germany Bacterial & Plasmid Vectors Market, Segmentation By Host Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
17.2. Germany Bacterial & Plasmid Vectors Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
18. France Bacterial & Plasmid Vectors Market
18.4. France Bacterial & Plasmid Vectors Market, Segmentation By Host Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
18.5. France Bacterial & Plasmid Vectors Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
19. Eastern Europe Bacterial & Plasmid Vectors Market
19.1. Eastern Europe Bacterial & Plasmid Vectors Market Overview
19.2. Eastern Europe Bacterial & Plasmid Vectors Market, Segmentation By Host Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
19.3. Eastern Europe Bacterial & Plasmid Vectors Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
20. Russia Bacterial & Plasmid Vectors Market
20.1. Russia Bacterial & Plasmid Vectors Market, Segmentation By Host Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
20.2. Russia Bacterial & Plasmid Vectors Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
21. North America Bacterial & Plasmid Vectors Market
21.1. North America Bacterial & Plasmid Vectors Market Overview
21.2. North America Bacterial & Plasmid Vectors Market, Segmentation By Host Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
21.3. North America Bacterial & Plasmid Vectors Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
22. USA Bacterial & Plasmid Vectors Market
22.1. USA Bacterial & Plasmid Vectors Market Overview
22.2. USA Bacterial & Plasmid Vectors Market, Segmentation By Host Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
22.3. USA Bacterial & Plasmid Vectors Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
23. South America Bacterial & Plasmid Vectors Market
23.1. South America Bacterial & Plasmid Vectors Market Overview
23.2. South America Bacterial & Plasmid Vectors Market, Segmentation By Host Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
23.3. South America Bacterial & Plasmid Vectors Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
24. Brazil Bacterial & Plasmid Vectors Market
24.1. Brazil Bacterial & Plasmid Vectors Market, Segmentation By Host Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
24.2. Brazil Bacterial & Plasmid Vectors Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
25. Middle East Bacterial & Plasmid Vectors Market
25.1. Middle East Bacterial & Plasmid Vectors Market Overview
25.2. Middle East Bacterial & Plasmid Vectors Market, Segmentation By Host Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
25.3. Middle East Bacterial & Plasmid Vectors Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
26. Africa Bacterial & Plasmid Vectors Market
26.1. Africa Bacterial & Plasmid Vectors Market Overview
26.2. Africa Bacterial & Plasmid Vectors Market, Segmentation By Host Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
26.3. Africa Bacterial & Plasmid Vectors Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
27. Bacterial & Plasmid Vectors Market Competitive Landscape And Company Profiles
27.1. Bacterial & Plasmid Vectors Market Competitive Landscape
27.2. Bacterial & Plasmid Vectors Market Company Profiles
27.2.1. Sigma-Aldrich Inc.
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. ATUM
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. QIAGEN
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Promega Corporation
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Thermo Fisher Scientific Inc.
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance
28. Bacterial & Plasmid Vectors Pipeline Analysis29. Key Mergers And Acquisitions In The Bacterial & Plasmid Vectors Market30. Bacterial & Plasmid Vectors Market Future Outlook and Potential Analysis
31. Appendix
31.1. Abbreviations
31.2. Currencies
31.3. Research Inquiries
31.4. About the Publisher
31.5. Copyright And Disclaimer

Executive Summary

Major players in the bacterial & plasmid vectors market are Sigma-Aldrich Inc., ATUM, QIAGEN, Promega Corporation, Thermo Fisher Scientific, Inc., GenScript Biotech Corporation, Takara Bio Inc., IBA GmbH, Bio-Rad Laboratories and New England Biolabs.

The global bacterial & plasmid vectors market is expected to grow from $0.51 billion in 2021 to $0.57 billion in 2022 at a compound annual growth rate (CAGR) of 12.2%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $0.92 billion in 2026 at a CAGR of 12.6%.

The bacterial & plasmid vectors market consists of sales of bacterial & plasmid vectors and related services by entities (organizations, sole traders and partnerships) that develop bacterial and plasmid vectors for biotechnological applications. Bacterial vectors are DNA molecules that are the basic tool of genetic engineering is used to introduce foreign genetic material into a host to replicate and amplify the foreign DNA sequences as a recombinant molecule. The vectors are used for introducing definite gene into the target cell and command the cell’s mechanism for protein synthesis to produce the protein encoded by the gene. These are used for the production of protein in biotechnology applications.

The main types of hosts in bacterial & plasmid vectors are E.coli expression vectors and other bacterial expression vectors. The E. coli expression system enables for rapid recombinant protein expression and subsequent large-scale, cost-effective production. For non-glycosylated proteins, this technique is ideal for antigen expression and functional protein expression. The different applications include genetics, molecular biology, bioinformatics, others and involves various sectors such as hospitals, homecare, specialty clinics, others.

North America was the largest region in the bacterial & plasmid vectors market in 2021. Middle East is expected to be the largest growing region in the forecast period. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Increasing the prevalence of cancer and infectious diseases is anticipated to boost the demand for bacterial & plasmid vectors market over the coming years. Bacteria are used as vectors for the delivery of recombinant proteins into target cells for the treatment of cancer and various infectious diseases. According to the World Health Organization (WHO), cancer is a second leading cause of death worldwide, in 2020, the total cancer burden in the world increased to 19.3 million new cases and is predicted to rise to 28.4 million new cancer cases in 2040 . Moreover, according to the WHO, the world is facing many public health threats which include various issues from climate change to inadequate healthcare facilities, wherein infectious diseases dominated WHO’s list of 2019 health threats. Therefore, the growing prevalence of cancer and various infectious diseases and surging demand for bacterial & plasmid vectors for gene therapy is projected to propel the market revenues for bacterial & plasmid vectors’ market.

The high cost of gene therapy is expected to limit the growth of the bacterial & plasmid vectors market during the forecast period. Gene therapy utilizes genuine gene to prevent or treat diseases which utilizes bacteria or plasmids as vectors. The cost of gene therapy treatments approved by the Food and Drug Administration is between $0.3 million and $2.1 million. Moreover, the cost of Luxturna gene therapy for certain inherited retinal diseases (IRDs) is $0.4 million per eye and LentiGlobin a gene therapy by Bluebird Bio designed to increase the levels of hemoglobin costs around $2.1 million. Stringent government regulations, long approval processes, and production costs are the major factors leading to the high cost of gene therapy. Thus, the high cost of gene therapy is to hinder the growth of the bacterial & plasmid vectors market in the near future.

The focus areas for many companies in the bacterial and plasmid vectors market has shifted to increasing mergers and acquisitions to acquire more production capabilities. Large prime manufactures are forming joint ventures or buying small or midsized companies to acquire new capabilities, or gain access to new markets. For instance, Vectalys, a France-based company engaged in manufacturing and commercializing lentiviral vectors for gene delivery and FlashCell, a company engineering non-integrating lentiviral delivered RNA therapeutics announced their merger to create new gene therapy company- Flash Therapeutics.

In February 2021, Catalent, a US-based pharmaceutical company acquired Delphi Genetics for an undisclosed amount. Through this acquisition Catalent's growth of plasmid capabilities in the United States at its Rockville facility will be accelerated. Delphi Genetics is a Belgium based contract development and manufacturing company specializing on plasmid DNA (pDNA) cell and gene therapy (CDMO).

The countries covered in the bacterial & plasmid vectors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Sigma-Aldrich inc.
  • ATUM
  • QIAGEN
  • Promega Corporation
  • Thermo Fisher Scientific inc.
  • GenScript Biotech Corporation
  • Takara Bio inc.
  • IBA GmbH
  • Bio-Rad Laboratories
  • New England Biolabs
  • Agilent Technologies
  • Life Technologies Corporation
  • Clontech Laboratories inc.
  • DNA TwoPointO inc.

Methodology

Loading
LOADING...